Growth Metrics

Omeros (OMER) Total Liabilities (2010 - 2026)

Omeros recorded quarterly Total Liabilities of $349.5 million in Q1 2026, down 21.79% quarter-over-quarter from $446.9 million in Q4 2025, and down 22.11% year-over-year from $448.7 million in Q1 2025.

Omeros' Total Liabilities history runs 17 years deep, the most recent figure standing at $349.5 million for Q1 2026.

  • In Q1 2026, Total Liabilities fell 22.11% year-over-year to $349.5 million; the TTM figure through Mar 2026 stood at $349.5 million (down 22.11% YoY), while the FY2025 annual figure was $446.9 million, down 2.79% from the prior year.
  • Total Liabilities came in at $349.5 million for Q1 2026 at Omeros, down from $446.9 million in the prior quarter.
  • In the past five years, Total Liabilities ranged from a high of $508.8 million in Q1 2024 to a low of $349.5 million in Q1 2026.
  • A 5-year average of $451.9 million and a median of $459.7 million in 2024 frame the typical range for Total Liabilities.
  • Across the five-year window, Total Liabilities surged 35.01% in 2023 and decreased 22.11% in 2026, its largest moves.
  • Omeros' Total Liabilities stood at $505.3 million in 2022, then decreased by 20.19% to $403.3 million in 2023, then rose by 14.0% to $459.7 million in 2024, then dropped by 2.79% to $446.9 million in 2025, then retreated by 21.79% to $349.5 million in 2026.
  • According to Business Quant data, Total Liabilities over the past three periods registered $349.5 million, $446.9 million, and $406.2 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Liabilities (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - 16.35 Mn
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - 1.74 Mn
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn 731.60 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - 177.22 Mn
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - 19.51 Mn
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 7.12 Bn
7 Evaxion A 62.56 Bn 62.54 Bn - 10.44 Mn
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn 9.45 Bn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 4.05 Bn
10 Omeros 772.03 Mn 636.71 Mn 9.31 Mn 349.51 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 349.51 Mn
Dec 31, 2025 446.86 Mn
Sep 30, 2025 406.18 Mn
Jun 30, 2025 429.25 Mn
Mar 31, 2025 448.71 Mn
Dec 31, 2024 459.69 Mn
Sep 30, 2024 467.51 Mn
Jun 30, 2024 480.91 Mn
Mar 31, 2024 508.82 Mn
Dec 31, 2023 403.25 Mn
Sep 30, 2023 507.02 Mn
Jun 30, 2023 506.91 Mn
Mar 31, 2023 505.20 Mn
Dec 31, 2022 505.29 Mn
Sep 30, 2022 503.87 Mn
Jun 30, 2022 378.34 Mn
Mar 31, 2022 374.19 Mn
Dec 31, 2021 395.49 Mn
Sep 30, 2021 386.13 Mn
Jun 30, 2021 391.69 Mn
Mar 31, 2021 383.40 Mn
Dec 31, 2020 301.79 Mn
Sep 30, 2020 314.40 Mn
Jun 30, 2020 231.96 Mn
Mar 31, 2020 250.08 Mn
Dec 31, 2019 245.99 Mn
Sep 30, 2019 231.18 Mn
Jun 30, 2019 220.03 Mn
Mar 31, 2019 222.27 Mn
Dec 31, 2018 196.09 Mn
Sep 30, 2018 164.61 Mn
Jun 30, 2018 162.65 Mn
Mar 31, 2018 118.25 Mn
Dec 31, 2017 119.14 Mn
Sep 30, 2017 116.31 Mn
Jun 30, 2017 115.20 Mn
Mar 31, 2017 106.52 Mn
Dec 31, 2016 104.73 Mn
Sep 30, 2016 95.54 Mn
Jun 30, 2016 95.10 Mn
Mar 31, 2016 76.71 Mn
Dec 31, 2015 75.23 Mn
Sep 30, 2015 50.42 Mn
Jun 30, 2015 50.71 Mn
Mar 31, 2015 53.07 Mn
Dec 31, 2014 53.49 Mn
Sep 30, 2014 51.88 Mn
Jun 30, 2014 51.60 Mn
Mar 31, 2014 50.86 Mn
Dec 31, 2013 34.92 Mn
Sep 30, 2013 35.91 Mn
Jun 30, 2013 35.31 Mn
Mar 31, 2013 33.56 Mn
Dec 31, 2012 33.11 Mn
Sep 30, 2012 33.58 Mn
Jun 30, 2012 30.60 Mn
Mar 31, 2012 33.77 Mn
Dec 31, 2011 32.54 Mn
Sep 30, 2011 30.91 Mn
Jun 30, 2011 30.93 Mn
Dec 31, 2010 25.23 Mn